| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 43.15B | 43.34B | 42.85B | 43.21B | 40.44B | 35.87B |
| Gross Profit | 28.56B | 28.69B | 28.72B | 29.16B | 27.74B | 23.91B |
| EBITDA | 2.56B | 2.67B | 2.92B | 4.17B | 3.40B | 2.76B |
| Net Income | 742.00M | 822.00M | 1.46B | 1.87B | 1.20B | 840.00M |
Balance Sheet | ||||||
| Total Assets | 49.53B | 49.68B | 49.85B | 47.96B | 46.51B | 44.92B |
| Cash, Cash Equivalents and Short-Term Investments | 17.37B | 18.20B | 19.34B | 20.20B | 19.57B | 19.09B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 22.95B | 22.62B | 22.98B | 22.03B | 21.92B | 19.66B |
| Stockholders Equity | 26.57B | 27.04B | 26.86B | 25.91B | 24.58B | 25.25B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 812.00M | 148.00M | 1.71B | 1.62B | 3.38B |
| Operating Cash Flow | 0.00 | 2.58B | 2.14B | 2.93B | 2.50B | 4.23B |
| Investing Cash Flow | 0.00 | -2.91B | -2.17B | -1.42B | -1.18B | -885.00M |
| Financing Cash Flow | 0.00 | -911.00M | -919.00M | -924.00M | -924.00M | -1.11B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | ¥14.74B | 7.61 | ― | 3.28% | 5.75% | 26.35% | |
66 Neutral | ¥34.73B | 6.92 | ― | 1.81% | 0.22% | 4.15% | |
64 Neutral | ¥26.36B | 14.66 | ― | 3.42% | 2.30% | 19.67% | |
64 Neutral | ¥19.64B | 22.30 | ― | 1.11% | 13.45% | -5.58% | |
64 Neutral | ¥20.55B | 33.88 | ― | 0.91% | 13.12% | 27.53% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
48 Neutral | ¥41.05B | -33.63 | ― | 1.23% | -14.80% | 89.50% |